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Moreover, central integration of vomiting occurs at the medullary level and it has been demonstrated that acetylcholine plays a mediator role in some of the medullary centers. We have shown that acetylcholine plays an excitatory transmitter role in the medullary vasomotor center (2). Varma (3) has provided evidence for cholinergic mediation in vagal nucleus. It was, therefore, thought worthwhile to investigate the role of acetylcholine in vomiting induced by various emetic agents using hemicholinium as a pharmacological tool.
Methods and material: The present study was carried out in dogs of either sex weighing 7-12 kg. A metalic cannula was chronically implanted into one of the lateral cerebral ventricles by the method of Bhargava and Tangri (4). The reliability of the cannulation was tested by the emetic response to 1.0 pg of apomorphine given intracereventricularly (ICV) two days after implantation of the cannula. Only those dogs which gave a positive emetic response within 5 minutes of injection were included in the study. The animals were fed 30 minutes before eliciting an emetic response except in the case of copper sulfate which was given empty stomach. Hemicholinium (HC3) was injected ICV two hours before administering the emetic agents. The 100% effective emetic doses of apomorphine (5), sodium salicylate (6), ouabain (7) pilocarpine (1) protoveratrine (8) and copper sulfate (9) were used for eliciting the response. Results: Hemicholinium was administered intracerebroventricularly in 21 dogs in doses ranging from 0.1 to 2.0 mg but none of the dogs showed emesis. Doses above 1.5 mg caused death of the animal within 12 hours and so the dose of 1.0 mg was selected for treating the animals 2 hours prior to the emetic challenge.
This dose of hemicholinium produced marked sedation in all the animals but the emetic response to 100% effective doses of apomorphine, sodium salicylate, ouabain, protoveratrine, copper sulfate and pilocarpine was not affected in these animals ( Table 1) .
Discussion : Medullary vomiting center can be stimulated by afferents from different parts of the body.
In the present study we selected emetic agents which have different sites of action. Pilocarpine acts on fron tal lobe (1), apomorphine acts on chemoreceptor trigger zone (CTZ), sodium salicylate and ouabain act on CTZ as well as on other peripheral sites (6, 10). Protoveratrine acts on nodose ganglion (11) while oral copper sulfate acts on gastrointestinal receptors (9) . The purpose of employing these drugs with different sites of action was to explore the possibility of cholinergic mediation in central integration of emesis induced by exciting different afferent pathways.
The results of the present study show that central administration of hemicholinium neither elicits an emetic response nor blocks the emesis produced by pilocarpine, apomorphine, sodium salicylate, ouabain, protoveratrine and copper sulfate. Hemicholinium blocks the synthesis of acetylcholine (12) and it would have blocked the emesis of various emetic agents, had acetylcholine been the transmitter in central regulation of emesis. It is, therefore, concluded that acetylcholine does not play a part in central integration of emesis.
